9 Oct 2016
New Grant Awarded: A novel platform for rapid and direct detection of diarrheagenic pathogens.
The following grant has been awarded by the AMR network:
A novel platform for rapid and direct detection of diarrheagenic pathogens.
Existing diagnostics is primarily based on cell culture and microscopy, which takes several days to arrive at a result. Current clinical practice is largely based on empirical prescriptions of antibiotics, which is often inappropriate or broad-spectrum. This has led to the alarming global threat of antimicrobial resistance (AMR), which means existing drugs will soon be ineffective even for common illnesses.
This project aims to develop a rapid diagnostic test platform that can detect the causal pathogens for diarrhoea directly from the sample. A novel acoustic technique will be combined with a polymer based receptor for enhanced robustness for use in tropical resource-limited countries, which see the largest prevalence of infectious diseases. This portable and entirely electronic test platform will potentially allow timely and appropriate first line of treatment and limit AMR.